Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Lutetium-177 × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 4 Neuroendocrine Tumors 2 Urogenital Neoplasms 1 Prostatic Diseases 1 Oligometastatic Prostate Cancer (OMPC) 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Carcinoma, Merkel Cell 1 Carcinoma 1 Advanced Gastroenteropancreatic Neuroendocrine Tumor 1

Interventions

Rituximab 7 Cyclophosphamide 5 Lenalidomide 4 ibrutinib 3 Vincristine 3 Prednisone 3 venetoclax 2 orelabrutinib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Doxorubicin 2 CT-P10 2 zanubrutinib 1 tafasitamab 1 prednylidene 1 polatuzumab vedotin 1 obinutuzumab 1 ianalumab 1 fludarabine phosphate 1 fludarabine 1 deltacortene 1 cc-486 1 acalabrutinib 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 R-CHOP protocol 1 Pharmacogenomic Testing 1 Peripheral Blood Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡